Dotti Patch, Extended Release
Product Images NDC 72162-2035

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Dotti (NDC 72162-2035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Dotti Estradiol Transdermal System 1)

Chemical structure of estradiol, showing its characteristic steroid backbone with hydroxyl groups at specific positions.*

FDA Label Image

4a (Dotti Estradiol Transdermal System 10)

An instructional illustration showing hands peeling apart a protective backing from a rectangular adhesive patch, indicating the preparation step for applying a transdermal patch.*

FDA Label Image

4b (Dotti Estradiol Transdermal System 11)

An illustration showing two hands removing a transdermal patch from its backing. The image demonstrates how to peel the patch before application to the skin.*

FDA Label Image

4c (Dotti Estradiol Transdermal System 12)

An instructional illustration showing a hand holding a small round patch near the abdomen, demonstrating application of a transdermal patch to the skin. The image likely relates to the proper placement of the DOTTI estradiol transdermal patch.*

FDA Label Image

4d (Dotti Estradiol Transdermal System 13)

An instructional illustration showing a person applying a DOTTI estradiol transdermal patch to the skin. The image depicts hands positioning the patch onto the skin, indicating the method for proper patch application.*

FDA Label Image

4e (Dotti Estradiol Transdermal System 14)

An instructional illustration showing the application of a DOTTI estradiol extended-release transdermal patch. The image depicts hands placing the patch onto the skin of the lower abdomen or hip area, demonstrating correct placement for use.*

FDA Label Image

4f (Dotti Estradiol Transdermal System 15)

An illustration showing a hand with a transdermal patch applied to the forearm, demonstrating the placement of a DOTTI estradiol extended-release patch for transdermal use.*

FDA Label Image

4g (Dotti Estradiol Transdermal System 16)

An instructional line drawing showing a hand applying a round transdermal patch to the skin of an abdomen. The image illustrates the proper placement of the DOTTI estradiol 0.075 mg/day extended-release patch on the body.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 2)

An illustration showing a cross-sectional view of the DOTTI estradiol transdermal patch. It labels three layers: (1) Backing, (2) Adhesive containing estradiol, and (3) Protective liner, highlighting the patch's structure for drug delivery.*

FDA Label Image

Figure 1 (Dotti Estradiol Transdermal System 3)

A line graph depicting estradiol plasma concentration (pg/mL) over time (days) for four different dosages of a transdermal estradiol patch: 0.1 mg/day, 0.075 mg/day, 0.05 mg/day, and 0.03/5 mg/day. Concentrations vary over a 4-day period, showing trends for each dosage.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 4)

A bar graph comparing mean changes from baseline at Weeks 4, 8, and 12 for Estradiol 0.0375 mg/day versus placebo. Estradiol shows greater reductions at all time points with statistical significance indicated. The graph includes sample sizes and standard deviations for each group.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 5)

A line graph depicting percentage change from baseline over treatment duration in weeks (26, 52, 78, 104) for different doses of estradiol (0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day) compared to placebo. The graph shows trends for each dose and placebo across the four time points.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 6)

A line graph depicting the percentage change from baseline versus treatment duration in weeks (26, 52, 78, 104) for five groups: Estradiol 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and placebo. Statistical significance markers (p<0.05) indicate differences between various estradiol doses compared to placebo at multiple time points.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 7)

This text panel for DOTTI (estradiol transdermal system, USP) instructs patients to change the patch only on two specified days of the week. It lists pairs of days with checkboxes: Sun/Wed, Mon/Thu, Tue/Fri, Wed/Sat, Thu/Sun, Fri/Mon, and Sat/Tue, allowing selection of the patch change schedule. The panel is focused on usage timing for the estradiol patch.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 8)

An instructional illustration showing the application of a small circular transdermal patch on a person's abdomen using a fingertip, indicating site placement for DOTTI estradiol extended release patches.*

FDA Label Image

3 (Dotti Estradiol Transdermal System 9)

DOTTI estradiol 0.075 mg/day transdermal extended-release patch packaging label by Bryant Ranch Prepack, NDC 72162-2035. The label features a minimalistic design with a curved line and a single character on a white background.*

FDA Label Image

Label (Lbl721622035)

Label for DOTTI (estradiol transdermal system, USP) delivering 0.075 mg/day. The label shows the product NDC 72162-2035-2, indicates 8 systems per package, and includes storage instructions at 20° to 25°C with permitted excursions. The labeler is Bryant Ranch Prepack, with manufacturing by Amneal Pharmaceuticals, LLC. Additional warnings specify transdermal use only and to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.